PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Mar-2021 ​​​​​​​PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR 2020 PAION AG
30-Mar-2021 PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy PTC Therapeutics
30-Mar-2021 Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis Genmab
30-Mar-2021 VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
30-Mar-2021 Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS Amryt
30-Mar-2021 NDA Group Releases Data Comparing FDA and EMA drug approvals in 2020 NDA Group
30-Mar-2021 Tiziana Announces the FDA Has Allowed Treatment for a Secondary Progressive Multiple Sclerosis (SPMS) Patient for the Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program Tiziana Life Sciences plc
30-Mar-2021 PENTAX Medical’s online hygiene event provides platform for expert insights: Ways to further improve patient safety in endoscopy PENTAX Medical
30-Mar-2021 Santhera Completes Capital Increase for Financing Arrangements Santhera
30-Mar-2021 Takeda Builds on 30-Year Partnership with the World Federation of Hemophilia with a Five-Year Product Donation to the Humanitarian Aid Program Takeda
30-Mar-2021 Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV B3C newswire
30-Mar-2021 ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development ENPICOM
30-Mar-2021 Albumedix announces recombinant human albumin supply partnership with FUJIFILM Wako Pure Chemical Corporation for the Japanese, Chinese and Hong Kong markets Albumedix
30-Mar-2021 Vita 34 continues to grow in 2020 in core markets after good year-end business Vita 34 AG
30-Mar-2021 Dermapharm posts growth despite COVID-19 pandemic - consolidated revenue and EBITDA continue to rise Dermapharm Holding SE
30-Mar-2021 Relief Confirms Release of 60-Day Findings from Phase 2b/3 Clinical Trial of Intravenous RLF-100(TM) (aviptadil) RELIEF THERAPEUTICS Holdings AG
29-Mar-2021 HAEMATO AG successfully completes capital increase HAEMATO AG
29-Mar-2021 BioMed X Institute Launches New Global Call in Neuroscience in Collaboration with Boehringer Ingelheim B3C newswire
27-Mar-2021 ​​​​​​​PAION RECEIVES EUROPEAN COMMISSION APPROVAL OF BYFAVO(R) (REMIMAZOLAM) FOR PROCEDURAL SEDATION PAION AG
26-Mar-2021 Douglas GmbH: Announces Pricing of €1,305 Million 6.000% Senior Secured Notes due 2026 and €475 Million 8.250% / 9.000% Senior PIK Notes due 2026 Douglas GmbH